Concepedia

Robert L. Redner

RL

Statistics

Publications

38

Citations

3.8K

H-Index

21

Active since

1979

Affiliations

UPMC Hillman Cancer Center(Current)

University of Pittsburgh

National Heart Lung and Blood Institute

University of Pittsburgh Medical Center

Memorial Sloan Kettering Cancer Center

Robert L. Redner is an author at UPMC Hillman Cancer Center specializing in medicine, hematology, and immunology.

ORCID

Top concepts

Publications per year

1979–2024

38

Publications

38

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial

David J. Kuter, James B. Bussel, Roger M. Lyons et al. · The Lancet · 2008 · 851 citations

, , +9

ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex

Jianxiang Wang, Taizo Hoshino, Robert L. Redner et al. · Proceedings of the National Academy of Sciences · 1998 · 518 citations · Full text

, , +18

An oligomer complementary to c-myc mRNA inhibits proliferation of HL-60 promyelocytic cells and induces differentiation.

J T Holt, Robert L. Redner, Arthur W. Nienhuis · Molecular and Cellular Biology · 1988 · 473 citations · Full text

, , +18

Inhibitors of histone deacetylase relieve ETO-mediated repression and induce differentiation of AML1-ETO leukemia cells.

Jianxiang Wang, Yogen Saunthararajah, Robert L. Redner et al. · PubMed · 1999 · 197 citations

, , +21

Chromatin Remodeling and Leukemia: New Therapeutic Paradigms

Robert L. Redner, Jianxiang Wang, Johnson M. Liu · Blood · 1999 · 174 citations

1–5 of 38